长康5年报逾期未披露，受损股民可关注索赔

Group 1 - The company, Changjiang Runfa Health Industry Co., Ltd. (Changkang 5), announced that it would be unable to disclose its 2024 annual report on time due to late entry of accountants [1] - As a result of failing to disclose the report by the deadline, the company's stock trading method changed from "5 transfers per week" to "1 transfer per week" [1] - Southwest Securities, as the continuous supervision sponsor for Changkang 5, issued a risk warning to investors on May 6, 2025 [1] Group 2 - Changkang 5 has a history of issues, including receiving a notice of investigation from the China Securities Regulatory Commission due to fund occupation and internal control audit report receiving a negative opinion [2] - As of May 6, 2024, the amount of funds occupied by the controlling shareholder was 348,541.48 million, accounting for 93.44% of the net assets at the end of 2023, indicating severe financial issues [2] - The company announced the termination of its stock listing on August 15, 2024, and transitioned to the New Third Board [2] Group 3 - Investors who suffered losses may be eligible for compensation if they bought shares between April 30, 2024, and sold or held them after May 1, 2024, with the final eligibility determined by the court [3] - The media outlet is organizing a financial team to provide consultation services for investors seeking to recover losses through legal means [3]